Ottawa Heart Institute Research Corporation: Cardiovascular Diseases trials

The registry lists 15 Cardiovascular Diseases studies with Ottawa Heart Institute Research Corporation as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 3 2Phase 4 3No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Exercise Training in Women With Heart Disease 2RecruitingNCT06494163Not applicable
• Exercise Training in Women With Cardiac DevicesCompletedNCT05946304Not applicable
• Reexamining Her Cardiovascular Risk - Ottawa WomeN's Longitudinal Cohort StudyActive, not recruitingNCT05632601Not applicable
• Exercise Training in Women With Heart DiseaseCompletedNCT04781504Not applicable
• The COVID-RASi Trial (COVID-19)CompletedNCT04591210Phase 3
• The Role of a Motion Sensor With Accompanying Web Application on Step Counts, Energy Balance, and Metabolic Markers in NursesCompletedNCT04524572Not applicable
• Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of ColchicineCompletedNCT04181996Phase 3
• Healing Hearts Together: Evaluating a Couples-based Intervention to Improve Health OutcomesCompletedNCT03938116Not applicable
• Sleep to Your Heart's Content - Insomnia Intervention for Cardiac PatientsTerminatedNCT03250468Not applicable
• Feasibility and Usability of a Pedometer in a Cardiovascular Disease Prevention Program for French-speaking CanadiansCompletedNCT02837471Not applicable
• Decision Support for Adults Facing Implantable Cardioverter-Defibrillator Pulse Generator ReplacementCompletedNCT02668900Not applicable
• The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive PatientsCompletedNCT02234492Phase 4
• Prognostic Value of Stress SPECT Myocardial Perfusion Imaging With Half Dose 99mTc-TetrofosminCompletedNCT02019212
• Reducing Cardiovascular Disease by Combining Smoking Cessation Pharmacotherapy and Behavioural CounselingCompletedNCT01623505Phase 4
• Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart DiseaseCompletedNCT00959972Phase 4